Upgrade to SI Premium - Free Trial

Forest Road Acquisition Corp. (FRX)

12.00 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting May 21, 2026 6:01 PM - Globe NewsWire Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 18, 2026 4:30 PM - Globe NewsWire Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update May 14, 2026 6:30 AM - Globe NewsWire Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026 May 7, 2026 6:36 AM - Globe NewsWire Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center April 7, 2026 10:41 AM - Globe NewsWire Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 31, 2026 6:00 AM - Globe NewsWire Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update March 24, 2026 7:01 AM - Globe NewsWire Form 8-K FENNEC PHARMACEUTICALS For: Mar 16 March 16, 2026 5:21 PM - SEC Filing Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation March 16, 2026 8:08 AM - Globe NewsWire Form 4 FENNEC PHARMACEUTICALS For: Feb 18 Filed by: Andrade Robert March 11, 2026 7:02 PM - SEC Filing Full Article List